美格智能(002881.SZ)設立的投資公司已完成工商註冊登記手續
格隆匯1月2日丨美格智能(002881.SZ)公佈,公司於2019年12月4日召開第二屆董事會第十二次會議,審議通過了《關於在深圳設立投資公司的議案》,決定使用自有資金人民幣5000萬元在深圳設立投資公司,投資公司名稱以工商管理部門登記為準。
近日,公司設立的投資公司在工商部門完成了工商註冊登記手續,並取得了深圳市市場監督管理局頒發的《營業執照》,名稱為深圳市美格智投創業投資有限公司,經營範圍:創業投資業務;投資興辦實業(具體項目另行申報);投資諮詢(不含限制項目);投資顧問(不含限制項目)。(法律、行政法規、國務院決定禁止的項目除外,限制的項目須取得許可後方可經營)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.